Following a GMP inspection of Confab Laboratories’ facilities, systems, and procedures, the FDA has classified the facility as acceptable. No objectionable items where issued.

“Following this third inspection by FDA and being in business for 30 years, the company is renewing its capabilities of meeting quality requirements,” said Nathalie Brisson, general manager. “Confab’s personnel are ready to meet new and future challenges.”

This inspection follows the filing of several drug applications by Confab’s customers. The inspection covered the company’s services such as manufacturing, packaging and analytical labs. It was also Confab’s first FDA inspection of its internal QC lab.